Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis

Figure 1 Peripheral placental growth factor levels in liver cirrhosis and controls. Box plot graph; boxes correspond to the median value and interquartile range. PlGF: Placental growth factor.

Figure 2 Peripheral Nogo-A levels in liver cirrhosis and controls. Box plot graph; boxes correspond to the mean value and standard deviation.

Figure 3 Relationship between peripheral placental growth factor levels and hepatic venous pressure gradient. PlGF: Placental growth factor.

Figure 4 Receiver operating characteristic curves showing placental growth factor prediction of clinically significant portal hypertension (A) and severe portal hypertension (B). ROC: Receiver operating characteristic.

Figure 5 Relationship between peripheral Nogo-A levels and hepatic venous pressure gradient.

Figure 6 Receiver operating characteristic curves showing Nogo-A protein prediction of clinically significant portal hypertension (A) and severe portal hypertension (B). ROC: Receiver operating characteristic.